An independent source of information on U.S. brand name drugs for health professionals

Drugdocs Logo

An independent source of information on U.S. brand name drugs for health professionals

HomeDrugsGlossaryAboutContact Us

Menu

HomeDrugsGlossaryAboutContact Us

Drugs A-Z

ABCDE FGHIJKLMNOPQRSTUVWXYZ

DRUGS

A

B

C

D

E

F

G

H

I

J

K

L

M

N

O

P

Q

R

S

T

U

V

W

X

Y

Z

Xeglyze

Chemical Nameabametapir
Dosage FormLotion, (topical; 0.74%)
Drug ClassMiscellaneous
SystemSkin
CompanyGroupe Parima Inc.
Approval Year2020

Indication

  • For the topical treatment of head lice infestation in patients 6 months of age and older.
Last updated on 12/7/2020

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Xeglyze (abametapir) Prescribing Information.2020Groupe Parima Inc., Switzerland
Document TitleYearSource
Effect of a new head lice treatment, abametapir Lotion, 0.74%, on louse eggs: a randomized, double-blind study.2018Global Pediatric Health
Clinical studies evaluating abametapir lotion, 0.74%, for the treatment of head louse infestation.2018Pediatric Dermatology